Neutrophil‐to‐lymphocyte ratio as a prognostic marker for survival outcomes in women with cervical cancer and HIV infection | Synapse
April 17, 2026
Neutrophil‐to‐lymphocyte ratio as a prognostic marker for survival outcomes in women with cervical cancer and HIV infection
Key Points
This research aims to evaluate the effectiveness of the neutrophil-to-lymphocyte ratio (NLR) as a prognostic marker for survival outcomes in women with cervical cancer and HIV.
Conducted an observational study on women with cervical cancer and HIV.
Measured the neutrophil-to-lymphocyte ratio (NLR).
Assessed overall survival (OS) and progression-free survival (PFS) based on NLR values.
High NLR is associated with poor overall survival (OS).
High NLR also indicates reduced progression-free survival (PFS).
NLR serves as an independent predictor of survival outcomes.
Abstract
High NLR independently predicts poor OS and PFS in women with cervical cancer with HIV.